Acceptable Analytical Practices for Dissolution Testing of Poorly Soluble Compounds

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-12-02-2004, Volume 28, Issue 11

This article provides guidance for developing dissolution testing for poorly soluble compounds. It is the second of a series of articles based on material from a 2003 PhRMA workshop about acceptable analytical practices.

Related Content:

AnalyticsProcess ValidationManufacturingQuality SystemsPharmaceutical Technology-12-02-2004
FDA Reports on Status of Postmarketing Requirements and Postmarketing Commitments
Novartis’ Radioligand Therapy Gains FDA Nod for Pediatric Patients
Increasing mRNA Product Stability with Lyophilization